1. Home
  2. KNDI vs DBVT Comparison

KNDI vs DBVT Comparison

Compare KNDI & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • DBVT
  • Stock Information
  • Founded
  • KNDI 2002
  • DBVT 2002
  • Country
  • KNDI China
  • DBVT France
  • Employees
  • KNDI N/A
  • DBVT N/A
  • Industry
  • KNDI Auto Manufacturing
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KNDI Consumer Discretionary
  • DBVT Health Care
  • Exchange
  • KNDI Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • KNDI 91.2M
  • DBVT 102.0M
  • IPO Year
  • KNDI N/A
  • DBVT N/A
  • Fundamental
  • Price
  • KNDI $1.58
  • DBVT $4.40
  • Analyst Decision
  • KNDI
  • DBVT Strong Buy
  • Analyst Count
  • KNDI 0
  • DBVT 2
  • Target Price
  • KNDI N/A
  • DBVT $22.50
  • AVG Volume (30 Days)
  • KNDI 175.3K
  • DBVT 28.3K
  • Earning Date
  • KNDI 03-13-2025
  • DBVT 03-06-2025
  • Dividend Yield
  • KNDI N/A
  • DBVT N/A
  • EPS Growth
  • KNDI N/A
  • DBVT N/A
  • EPS
  • KNDI N/A
  • DBVT N/A
  • Revenue
  • KNDI $118,127,232.00
  • DBVT $12,515,000.00
  • Revenue This Year
  • KNDI N/A
  • DBVT N/A
  • Revenue Next Year
  • KNDI N/A
  • DBVT $2,860.00
  • P/E Ratio
  • KNDI N/A
  • DBVT N/A
  • Revenue Growth
  • KNDI N/A
  • DBVT 125.54
  • 52 Week Low
  • KNDI $0.89
  • DBVT $0.44
  • 52 Week High
  • KNDI $2.98
  • DBVT $5.42
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 78.86
  • DBVT 54.39
  • Support Level
  • KNDI $1.06
  • DBVT $4.18
  • Resistance Level
  • KNDI $1.12
  • DBVT $4.47
  • Average True Range (ATR)
  • KNDI 0.08
  • DBVT 0.28
  • MACD
  • KNDI 0.05
  • DBVT -0.04
  • Stochastic Oscillator
  • KNDI 88.71
  • DBVT 71.34

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: